Observed Signal · Jul 2, 2026 · Product Launch · Source: Digiday · Impact: 3/5 · Sentiment: Positive
Pharma advertisers adopt specialized ad tech
Pharmaceutical marketers are increasingly shifting ad dollars from traditional TV to digital channels and adopting specialized ad tech built for healthcare’s regulatory and privacy constraints. Industry data cited in the article forecasts healthcare and pharma digital ad spending at $26.2 billion versus $6.9 billion for traditional media, with social surpassing linear TV in 2025. Sources tell Digiday that niche vendors such as DeepIntent, Patient Point and Pulsepoint are winning share from legacy DSPs. DeepIntent, after a majority-stake sale to Vitruvian Partners for $637 million in late 2025, unveiled a healthcare-focused agentic AI product called Helix AI and new tools to buy premium live-streaming TV inventory, touting partnerships with major broadcasters and sports-rights holders. Agency and ad buyers say evolving FDA and state-level regulations are driving privacy‑forward targeting and measurement approaches.
Shows a notable sectoral shift: accelerating digital spend in pharma, private-equity-backed growth of a healthcare-focused adtech vendor (DeepIntent) and a new agentic AI product — all indicating structural change in how regulated categories buy and measure media.
Track DeepIntent Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Healthcare and pharma digital ad spending is forecast at $26.2 billion versus $6.9 billion for traditional media.
- Social media ad spend surpassed linear TV for healthcare advertisers in 2025.
- DeepIntent sold a majority stake to Vitruvian Partners for $637 million in late 2025.
- DeepIntent launched Helix AI, described as an agentic AI platform purpose-built for healthcare marketers.
- Vendors named as rising specialized pharma ad tech players include DeepIntent, Patient Point and Pulsepoint.
Connected Companies & Entities
3 Entities mapped“DeepIntent has emerged among this cohort after the DSP sold a majority stake in the company to Vitruvian Partners for $637 million in late 2...”
“The DSP sold a majority stake in the company to Vitruvian Partners for $637 million in late 2025....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Pharma Leads Digital Advertising Revolution with Precision and Privacy
Health care and life sciences have long lagged in digital advertising, relying on broad, mass-audience approaches. As precision medicine rises and the blockbuster drug era fades, broad strategies are giving way to precision engagement powered by privacy-preserving technology and AI-driven marketing. Tokenization and HIPAA-compliant frameworks enable joining first-, second-, and third-party data across clean rooms, unlocking actionable insights at speed while safeguarding patient privacy. Marketers can layer data to anticipate critical inflection points in the patient journey, such as cost or coverage barriers, and tailor messages to real-time access needs, including co-pay support. The evolution of health DSPs is moving from bidding-focused systems to platforms of intelligence, embedding planning, using agentic AI for optimization, and enabling real-time collaboration with data partners and clients. This shift aims to accelerate adoption of innovative therapies and improve outcomes, with pharma helping define the future of privacy-centric, precise digital advertising.
McDonald's Rolls Out AI-Powered Dynamic Pricing
McDonald's uses an AI-powered pricing platform, developed by Tiger Analytics, to set menu prices at nearly 14,000 US restaurants. The system analyzes millions of daily transactions to determine local willingness to pay, leading to significant price variations, such as a Big Mac costing $5.69 in one Fresno store and $6.89 in another just three kilometers away—a 21% difference. While McDonald's claims the tool is optional, internal documents reveal franchisees face pressure and are tracked for deviations from AI recommendations, causing conflicts as franchisees balance rising costs against AI-suggested price cuts to boost foot traffic. The practice raises antitrust and regulatory concerns, with the FTC warning that undisclosed personalized pricing may be illegal, and states like Maryland and New York enacting laws. A 2023 Connecticut lawsuit alleging the system suggested an $18 Big Mac meal was dismissed.
Amazon Ads unifies buying tools, boosts AI in campaigns
At its unBoxed conference, Amazon Ads announced major platform changes, renaming its unified platform to Amazon Ads Agent and launching Full-Funnel Campaigns and DVA+. These products aim to collapse silos between sponsored ads, programmatic display, video, and TV buying, while giving Amazon's AI a larger role in planning, execution, and optimization. Advertisers can specify objectives, budget, and creative, with Amazon handling execution, making programmatic advertising more accessible to a wider range of advertisers. DVA+ offers a simplified interface for less experienced buyers with advanced settings for agencies. However, automation raises transparency concerns, especially amid FTC and state attorney general lawsuits alleging secret auction surcharges. Amazon disputes claims and has not committed to full auction-level transparency in new tools, prompting observers to advise caution and emphasize the need for advertisers to interrogate auditability, third-party data integration, and fee structures.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.